Want to see IN:PRIMO full AI Analyst Report?
Top Page
Primo Chemicals Limited
(PRIMO)
Select Model
Select Model
Rating:68Neutral
Price Target:
₹31.00
▲(30.75% Upside)
Action:Reiterated
Date:09/29/26
The score is driven primarily by improved financial performance (strong FY2026 revenue and free-cash-flow growth plus reduced leverage), supported by clear bullish price trends above major moving averages. This is tempered by a stretched valuation (P/E ~43) and still-thin/softening operating margins, which increase the risk of volatility if execution weakens.
Positive Factors
Strong FY2026 revenue growth
The sharp FY2026 revenue increase indicates materially stronger business activity and market demand. If the company can sustain this scale of growth, it should improve operating leverage, support reinvestment, and strengthen its competitive position over the next several quarters.
Negative Factors
Operating margin deterioration
The decline in operating margins shows that rapid revenue growth is not yet translating into proportionate operating profitability. Persistent cost pressure or weaker pricing could limit earnings conversion, reduce reinvestment capacity, and make future results more sensitive to execution.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong FY2026 revenue growth
The sharp FY2026 revenue increase indicates materially stronger business activity and market demand. If the company can sustain this scale of growth, it should improve operating leverage, support reinvestment, and strengthen its competitive position over the next several quarters.
Read all positive factors
Primo Chemicals Limited (PRIMO) vs. iShares MSCI India ETF (INDA)
Market Cap
₹6.59B
Dividend YieldN/A
Average Volume (3M)41.10K
Price to Earnings (P/E)40.8
Beta (1Y)0.61
Revenue Growth-2.70%
EPS Growth-15.41%
CountryIN
Employees365
SectorGeneral
Sector StrengthN/A
IndustryChemicals
Share Statistics
EPS (TTM)0.15
Shares Outstanding242,343,220
10 Day Avg. Volume82,547
30 Day Avg. Volume41,102
Financial Highlights & Ratios
PEG Ratio0.09
Price to Book (P/B)1.09
Price to Sales (P/S)0.79
P/FCF Ratio13.54
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Primo Chemicals Limited Business Overview & Revenue Model
Company Description
Headquartered in Chandigarh, India, Primo Chemicals Limited, established in 1975, is actively involved in the production and distribution of various chemical compounds across the country. The company's extensive product line encompasses industrial...
Primo Chemicals Limited Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
70
Positive
Cash Flow
74
Positive
| Breakdown | TTM | Mar 2025 | Mar 2024 |
|---|---|---|---|
Income Statement | |||
| Total Revenue | 2.90B | 5.62B | 5.56B |
| Gross Profit | 1.07B | 1.05B | 995.93M |
| EBITDA | 481.37M | 682.87M | 833.64M |
| Net Income | 37.51M | 153.71M | 35.60M |
Balance Sheet | |||
| Total Assets | 7.34B | 6.92B | 7.41B |
| Cash, Cash Equivalents and Short-Term Investments | 138.79M | 107.08M | 82.46M |
| Total Debt | 1.62B | 1.31B | 1.69B |
| Total Liabilities | 3.35B | 2.86B | 3.50B |
| Stockholders Equity | 3.99B | 4.06B | 3.91B |
Cash Flow | |||
| Free Cash Flow | 164.50M | 327.29M | 242.82M |
| Operating Cash Flow | 504.21M | 587.45M | 644.34M |
| Investing Cash Flow | -303.76M | -194.76M | -446.55M |
| Financing Cash Flow | -194.10M | -384.17M | -90.29M |
Primo Chemicals Limited Technical Analysis
Positive
23.71
Price Trends
22.87
Positive
23.35
Positive
22.45
Positive
Market Momentum
1.05
Negative
65.00
Neutral
74.77
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:PRIMO, the sentiment is Positive. The current price of 23.71 is above the 20-day moving average (MA) of 22.78, above the 50-day MA of 22.87, and above the 200-day MA of 22.45, indicating a bullish trend. The MACD of 1.05 indicates Negative momentum. The RSI at 65.00 is Neutral, neither overbought nor oversold. The STOCH value of 74.77 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:PRIMO.
Primo Chemicals Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | ₹6.59B | 40.77 | ― | ― | -2.70% | -15.41% | |
61 Neutral | ₹10.60B | 12.80 | ― | 0.35% | 13.23% | 22.22% | |
59 Neutral | ₹7.85B | 19.44 | ― | 0.79% | 49.58% | 43.22% | |
58 Neutral | ₹11.32B | 23.59 | ― | 0.99% | 1.41% | 946.41% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
49 Neutral | ₹6.16B | 30.50 | ― | 3.93% | -77.13% | ― | |
44 Neutral | ₹2.40B | -23.34 | ― | 0.42% | -39.30% | -700.73% |
* General Sector Average
IN:PRIMO
Primo Chemicals Limited
26.60
2.84
11.95%
IN:DIAMINESQ
Diamines & Chemicals Ltd.
239.70
-84.65
-26.10%
IN:DMCC
DMCC Speciality Chemicals Limited
312.40
2.13
0.69%
IN:INDOAMIN
Indo Amines Limited
141.50
3.16
2.28%
IN:UNIENTER
Uniphos Enterprises Limited
88.56
-55.65
-38.59%
IN:VALIANTORG
Valiant Organics Limited
456.30
117.35
34.62%
Primo Chemicals Limited Corporate Events
Primo Chemicals Moves to Merge Flow Tech Subsidiary for Streamlined Growth
Sep 25, 2026
Primo Chemicals Limited’s board has approved a draft scheme of amalgamation to merge its wholly owned subsidiary, Flow Tech Chemicals Private Limited, into the parent company, effective from October 1, 2026, subject to corporate, regulatory ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.